Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
you are here:
Success
Alert
Please select a Day.
Info

Ranbaxy Laboratories Ltd.

Sector : | Industry : Pharmaceuticals
Add to

Stock not traded in NSE.
Stock not traded in BSE.
NSE
MC Essentials
0% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Stock not eligible for rating

Financials
    Ownerships
      Industry Comparison
        Others
          Open 814.70
          Previous Close 859.80
          Volume 0.00
          Value (Lacs) 0.00
          VWAP 0.00
          Beta
          Mkt Cap (Rs. Cr.) 36,599
          High 869.70
          Low 809.45
          UC Limit 0.00
          LC Limit 0.00
          52 Week High 869.70
          52 Week Low 371.50
          Face Value 5.00
          All Time High 869.70
          All Time Low 129.55
          20D Avg Volume 0
          20D Avg Delivery(%) --
          Book Value Per Share 77.61
          Dividend Yield 0.00
          TTM EPS See historical trend -19.07
          TTM PE See historical trend --
          P/B See historical trend 11.08
          Sector PE 31.17

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          Stock not eligible for rating

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 1.05% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison

          Shareholding Pattern

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          4 out of 6 years Ranbaxy Laboratories has given negative returns in October.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          October 18.41% (2013) 11.33% -3.25% (2009) -1.81% 2.57%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Ranbaxy Labs

          What's your call on Ranbaxy Labs today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Corporate Action

          • No Data For Announcement.
          + See More
          Date Agenda
          + See More
          Ex-Date Type Dividend (Rs)
          + See More
          Announcement Date Ex-Bonus Ratio
          + See More
          Ex-Split Old FV New FV
          + See More
          Ex-Right Ratio Premium
          + See More
          Date Agenda
          + See More

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary

          No Data For Summary.

          Trend

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Ranbaxy Labs 859.90 - 36,602.80 - 33.34 0.00 - -879 6,864 5.46
          Brainbees Solu 348.40 -0.51 18,184.62 290.33 3.09 0.99 -44.51 59 2,470 0.00
          Sanstar 94.92 -1.06 1,729.86 - 7.66 30.69 -20.79 66 1,067 0.59
          CROPSTER AGRO 19.40 0.36 1,629.60 121.25 26.22 12.03 -18.14 12 194 0.00
          Shraddha Prime 220.00 2.04 888.82 27.85 11.55 31.26 174.73 24 155 2.40
          + See More

          About the Company

          Ranbaxy Laboratories Ltd. is pharmaceutical company. It develops, manufactures and markets generic, branded generic, over-the-counter products, anti-retrovirals, active pharmaceutical ingredients and intermediates. Its products include simvastatin, amoxyclav potassium, isotretinion, ciprofloxacin, isotretinon, cephalexin, ketorolac tromethamine, cefaclor, clarithromycin and cefuroxime axetil. The company was founded in 1961 and is based in Gurgaon, Haryana. Ranbaxy Laboratories Ltd. operates as a subsidiary of Daiichi Sankyo Company Ltd.
          {"success":1,"data":{"address":{"address1":"A-41, Industrial Area,","address2":"Phase-VIII-A,,Sahibzada Ajit Singh Nagar","city":"Mohali","state":"Punjab","pincode":"160071","telephone1":"0172-6678666","telephone2":"","fax1":"0172-5013376","fax2":"","email":"secretarial@ranbaxy.com","web":"http:\/\/www.ranbaxy.com"},"management":[{"name":"Tsutomu Une","designation":"Chairman"},{"name":"Arun Sawhney","designation":"Managing Director & CEO"},{"name":"Akihiro Watanabe","designation":"Director"},{"name":"Anthony H Wild","designation":"Director"},{"name":"Kazunori Hirokawa","designation":"Director"}],"registrars":{"name":"Alankit Assignment Ltd.","address1":"No.2E\/21, Alankit House,","address2":"Jhandewalan Extension,","address3":"","address4":"","telephone":"011-23541234, 42541234","fax":"011-42541201, 51540064","email":"info@alankit.com","internet":"http:\/\/www.alankit.com","city":"New Delhi","state":"Delhi","pincode":"110055"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"500359","nseId":"RANBAXY","series":"","isinid":"INE015A01028"}}}

          • Registered Office

          • Registrars

            • Address

              No.2E/21, Alankit House,,Jhandewalan Extension,

            • City

              New Delhi 110055

            • State

              Delhi

            • Tel. No.

              011-23541234, 42541234

            • Fax No.

              011-42541201, 51540064

            • Email

              info@alankit.com

            • Internet

              http://www.alankit.com

          • Management

            • Tsutomu Une

              Chairman

            • Arun Sawhney

              Managing Director & CEO

            • Akihiro Watanabe

              Director

            • Anthony H Wild

              Director

            • Kazunori Hirokawa

              Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              500359

            • NSE:

              RANBAXY

            • Series

            • ISIN

              INE015A01028

          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347